Furthermore, we identify recruitment of immunosuppressive Gr1+ myeloid cells via tumor cell expression of CXCL1, CXCL2, and CXCL8 (CXCR2 ligands) expression, which were substantially reduced with MEKi or CXCR2 blockade. This evidence concerns the gene CXCR2 and neoplasm.